FindTrial
Sign In

Genomic Analysis of Circulating Tumor Cells in Patients with Small Cell Lung Cancer

Genomic Analysis of Circulating Tumor Cells in Patients with Small Cell Lung Cancer - Genomic Analysis of Circulating Tumor Cells in Patients with Small Cell Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019666
Enrollment
60
Registered
2015-11-09
Start date
2015-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small Cell Lung Cancer

Interventions

None listed

Sponsors

Yamaoka Toshimitsu
Lead Sponsor
Center for Antibody and Vaccine Therapy, Research Hospital, The Institute of Medicine, University of Tokyo
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients newly diagnosed as having SCLC and starting chemotherapy or chemoradiotherapy

Exclusion criteria

Exclusion criteria: <20 years old

Design outcomes

Primary

MeasureTime frame
genomic analysis of circulating tumor cells in patients with small cell lung cancer by collecting blood samples at pre-, and post- treatment.—

Countries

Japan

Contacts

Public ContactYamaoka Toshimitsu

Showa University institute of molecular oncology

yamaoka.t@med.showa-u.ac.jp03-3784-8146

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026